Affinity Asset Advisors’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.45M | Hold |
390,000
| – | – | 0.74% | 34 |
|
|
2025
Q1 | $5.26M | Buy |
390,000
+230,386
| +144% | +$3.11M | 0.5% | 32 |
|
|
2024
Q4 | $3.06M | Sell |
159,614
-365,386
| -70% | -$7M | 0.41% | 44 |
|
|
2024
Q3 | $11.9M | Buy |
525,000
+375,000
| +250% | +$8.53M | 1.63% | 20 |
|
|
2024
Q2 | $1.95M | Buy |
+150,000
| New | +$1.95M | 0.23% | 59 |
|
|
2024
Q1 | – | Sell |
-50,000
| Closed | -$1.09M | – | 105 |
|
|
2023
Q4 | $1.09M | Buy |
+50,000
| New | +$1.09M | 0.2% | 60 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 82 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 80 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 79 |
|
|
2022
Q3 | – | Sell |
-20,660
| Closed | -$239K | – | 69 |
|
|
2022
Q2 | $239K | Sell |
20,660
-29,340
| -59% | -$339K | 0.1% | 37 |
|
|
2022
Q1 | $925K | Buy |
+50,000
| New | +$925K | 0.15% | 39 |
|